154 related articles for article (PubMed ID: 36466928)
21. Recipient immune repertoire and engraftment site influence the immune pathway effecting acute hepatocellular allograft rejection.
Horne PH; Lunsford KE; Walker JP; Koester MA; Bumgardner GL
Cell Transplant; 2008; 17(7):829-44. PubMed ID: 19044209
[TBL] [Abstract][Full Text] [Related]
22. Donor-derived cell-free DNA detects kidney transplant rejection during nivolumab treatment.
Hurkmans DP; Verhoeven JGHP; de Leur K; Boer K; Joosse A; Baan CC; von der Thüsen JH; van Schaik RHN; Mathijssen RHJ; van der Veldt AAM; Hesselink DA
J Immunother Cancer; 2019 Jul; 7(1):182. PubMed ID: 31300068
[TBL] [Abstract][Full Text] [Related]
23. LIMS1 risk genotype and T cell-mediated rejection in kidney transplant recipients.
Caliskan Y; Karahan G; Akgul SU; Mirioglu S; Ozluk Y; Yazici H; Demir E; Dirim AB; Turkmen A; Edwards J; Savran FO; Sever MS; Kiryluk K; Gharavi A; Lentine KL
Nephrol Dial Transplant; 2021 Nov; 36(11):2120-2129. PubMed ID: 33909908
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of CD4
McRae JL; Chia JS; Pommey SA; Dwyer KM
Nephrology (Carlton); 2017 Jul; 22(7):505-512. PubMed ID: 27517975
[TBL] [Abstract][Full Text] [Related]
25. Characterizing pre-transplant and post-transplant kidney rejection risk by B cell immune repertoire sequencing.
Pineda S; Sigdel TK; Liberto JM; Vincenti F; Sirota M; Sarwal MM
Nat Commun; 2019 Apr; 10(1):1906. PubMed ID: 31015506
[TBL] [Abstract][Full Text] [Related]
26. De Novo Donor-Specific Human Leukocyte Antigen Antibodies in Nonsensitized Kidney Transplant Recipients After T Cell-Mediated Rejection.
Chemouny JM; Suberbielle C; Rabant M; Zuber J; Alyanakian MA; Lebreton X; Carmagnat M; Pinheiro N; Loupy A; Van Huyen JP; Timsit MO; Charron D; Legendre C; Anglicheau D
Transplantation; 2015 May; 99(5):965-72. PubMed ID: 25340597
[TBL] [Abstract][Full Text] [Related]
27. Isolated De Novo Antiendothelial Cell Antibodies and Kidney Transplant Rejection.
Sánchez-Zapardiel E; Mancebo E; Díaz-Ordoñez M; de Jorge-Huerta L; Ruiz-Martínez L; Serrano A; Castro-Panete MJ; Utrero-Rico A; de Andrés A; Morales JM; Domínguez-Rodríguez S; Paz-Artal E
Am J Kidney Dis; 2016 Dec; 68(6):933-943. PubMed ID: 27599627
[TBL] [Abstract][Full Text] [Related]
28. Potential Utility of Neutrophil-to-Lymphocyte, Platelet-to-Lymphocyte, and Neutrophil, Lymphocyte, and Platelet Ratios in Differential Diagnosis of Kidney Transplant Acute Rejection: A Retrospective, Propensity Score Matched Analysis.
Kolonko A; Dwulit T; Skrzypek M; Więcek A
Ann Transplant; 2022 Dec; 27():e937239. PubMed ID: 36536590
[TBL] [Abstract][Full Text] [Related]
29. Longitudinal Analysis of the T-cell Receptor Repertoire in Graft-infiltrating Lymphocytes Following Hand Transplantation.
Kim JY; Lei Z; Maienschein-Cline M; Chlipala GE; Balamurugan A; McDiarmid SV; Azari K; Yang OO
Transplantation; 2021 Jul; 105(7):1502-1509. PubMed ID: 33208695
[TBL] [Abstract][Full Text] [Related]
30. Subclinical Rejection Phenotypes at 1 Year Post-Transplant and Outcome of Kidney Allografts.
Loupy A; Vernerey D; Tinel C; Aubert O; Duong van Huyen JP; Rabant M; Verine J; Nochy D; Empana JP; Martinez F; Glotz D; Jouven X; Legendre C; Lefaucheur C
J Am Soc Nephrol; 2015 Jul; 26(7):1721-31. PubMed ID: 25556173
[TBL] [Abstract][Full Text] [Related]
31. Bortezomib in the treatment of antibody-mediated rejection in pediatric kidney transplant recipients: A multicenter Midwest Pediatric Nephrology Consortium study.
Kizilbash S; Claes D; Ashoor I; Chen A; Jandeska S; Matar RB; Misurac J; Sherbotie J; Twombley K; Verghese P
Pediatr Transplant; 2017 May; 21(3):. PubMed ID: 28092129
[TBL] [Abstract][Full Text] [Related]
32. Effect of regulatory T cells on short-term graft outcome in kidney transplant recipients, a prospective observational, single-center study.
Bejugama K; Taduri G; Guditi S
Transpl Immunol; 2022 Aug; 73():101630. PubMed ID: 35643376
[TBL] [Abstract][Full Text] [Related]
33. Biological pathways and comparison with biopsy signals and cellular origin of peripheral blood transcriptomic profiles during kidney allograft pathology.
Van Loon E; Lamarthée B; de Loor H; Van Craenenbroeck AH; Brouard S; Danger R; Giral M; Callemeyn J; Tinel C; Cortés Calabuig Á; Koshy P; Sprangers B; Kuypers D; Gwinner W; Anglicheau D; Marquet P; Naesens M
Kidney Int; 2022 Jul; 102(1):183-195. PubMed ID: 35526671
[TBL] [Abstract][Full Text] [Related]
34. Serum & urinary interleukin-2 levels as predictors in acute renal allograft rejection.
Gupta RK; Jain M; Sharma RK
Indian J Med Res; 2004 Jan; 119(1):24-7. PubMed ID: 14997990
[TBL] [Abstract][Full Text] [Related]
35. Influence of immune activation on the risk of allograft rejection in human immunodeficiency virus-infected kidney transplant recipients.
Lorio MA; Rosa R; Suarez JF; Ruiz P; Ciancio G; Burke GW; Camargo JF
Transpl Immunol; 2016 Sep; 38():40-43. PubMed ID: 27297667
[TBL] [Abstract][Full Text] [Related]
36. Analysis of the peripheral T-cell repertoire in kidney transplant patients.
Miqueu P; Degauque N; Guillet M; Giral M; Ruiz C; Pallier A; Braudeau C; Roussey-Kesler G; Ashton-Chess J; Doré JC; Thervet E; Legendre C; Hernandez-Fuentes MP; Warrens AN; Goldman M; Volk HD; Janssen U; Wood KJ; Lechler RI; Bertrand D; Sébille V; Soulillou JP; Brouard S
Eur J Immunol; 2010 Nov; 40(11):3280-90. PubMed ID: 21061447
[TBL] [Abstract][Full Text] [Related]
37. Antibody-mediated allograft rejection is associated with an increase in peripheral differentiated CD28-CD8+ T cells - Analyses of a cohort of 1032 kidney transplant recipients.
Mai HL; Degauque N; Le Bot S; Rimbert M; Renaudin K; Danger R; Le Borgne F; Kerleau C; Tilly G; Vivet A; Delbos F; Walencik A; Giral M; Brouard S
EBioMedicine; 2022 Sep; 83():104226. PubMed ID: 35988467
[TBL] [Abstract][Full Text] [Related]
38. Urine immunocytology as a noninvasive diagnostic tool for acute kidney rejection: a single center experience.
Mihovilović K; Kardum-Skelin I; Ljubanović D; Sabljar-Matovinović M; Vidas Z; Knotek M
Coll Antropol; 2010 Mar; 34(1):63-7. PubMed ID: 20432735
[TBL] [Abstract][Full Text] [Related]
39. Immunoexpression of perforin and granzyme B on infiltrating lymphocytes in human renal acute allograft rejection.
Wagrowska-Danilewicz M; Danilewicz M
Nefrologia; 2003; 23(6):538-44. PubMed ID: 15002789
[TBL] [Abstract][Full Text] [Related]
40. Risk Factors of Antibody-Mediated Rejection and Predictors of Outcome in Kidney Transplant Recipients.
Yalcintas A; Sayin B; Turgut D; Atay G; Colak T; Haberal M
Exp Clin Transplant; 2020 Jan; 18(Suppl 1):29-31. PubMed ID: 32008489
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
